{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:11:26Z","timestamp":1787724686963,"version":"build-2784847793"},"update-to":[{"DOI":"10.1002\/14651858.cd011790","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,9,29]],"date-time":"2016-09-29T00:00:00Z","timestamp":1475107200000}}],"reference-count":109,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011790.pub2","type":"journal-article","created":{"date-parts":[[2016,9,29]],"date-time":"2016-09-29T19:10:20Z","timestamp":1475176220000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Pregabalin for pain in fibromyalgia in adults"],"prefix":"10.1002","volume":"2019","author":[{"given":"Sheena","family":"Derry","sequence":"first","affiliation":[{"name":"Oxford Oxfordshire UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malene","family":"Cording","sequence":"additional","affiliation":[{"name":"University of Copenhagen; Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J","family":"Wiffen","sequence":"additional","affiliation":[{"name":"Thame UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Law","sequence":"additional","affiliation":[{"name":"The Churchill Hospital; Pain Relief Unit; Oxford UK OX3 7LE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tudor","family":"Phillips","sequence":"additional","affiliation":[{"name":"University of Oxford; Pain Research and Nuffield Department of Clinical Neurosciences (Nuffield Division of Anaesthetics); Churchill Hospital Oxford UK OX3 7LJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R Andrew","family":"Moore","sequence":"additional","affiliation":[{"name":"Plymouth UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,9,29]]},"reference":[{"issue":"9","key":"10.1002\/14651858.CD011790.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.jpain.2008.03.013","article-title":"A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia","volume":"9","author":"Arnold","year":"2008","journal-title":"Journal of Pain"},{"issue":"10","key":"10.1002\/14651858.CD011790.pub2-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1185\/03007995.2014.928275","article-title":"Once daily controlled-release pregabalin in the treatment of patients with fibromyalgia: a phase III, double-blind, randomized withdrawal, placebo-controlled study","volume":"30","author":"Arnold","year":"2014","journal-title":"Current Medical Research and Opinion"},{"issue":"4","key":"10.1002\/14651858.CD011790.pub2-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1002\/art.20983","article-title":"Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial","volume":"52","author":"Crofford","year":"2005","journal-title":"Arthritis and Rheumatism"},{"issue":"3","key":"10.1002\/14651858.CD011790.pub2-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.pain.2008.02.027","article-title":"Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin","volume":"136","author":"Crofford","year":"2008","journal-title":"Pain"},{"issue":"7","key":"10.1002\/14651858.CD011790.pub2-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1097\/AJP.0b013e31823dd315","article-title":"Long-term maintenance of response across multiple fibromyalgia symptom domains in a randomized withdrawal study of pregabalin","volume":"28","author":"Pauer","year":"2012","journal-title":"Clinical Journal of Pain"},{"issue":"3","key":"10.1002\/14651858.CD011790.pub2-BIB0006|cit6","first-page":"502","article-title":"A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia","volume":"35","author":"Mease","year":"2008","journal-title":"Journal of Rheumatology"},{"issue":"2","key":"10.1002\/14651858.CD011790.pub2-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/acr.22111","article-title":"Twice daily versus once nightly dosing of pregabalin for fibromyalgia: a double-blind randomized clinical trial of efficacy and safety","volume":"66","author":"Nasser","year":"2014","journal-title":"Arthritis Care and Research"},{"issue":"5","key":"10.1002\/14651858.CD011790.pub2-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"R217","DOI":"10.1186\/ar4056","article-title":"A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia","volume":"14","author":"Ohta","year":"2012","journal-title":"Arthritis Research and Therapy"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0009|cit9","unstructured":"A 14-week, randomized, double-blind, placebo-controlled trial of pregabalin twice daily in patients with fibromyalgia PhRMA Web Synopsis"},{"issue":"12","key":"10.1002\/14651858.CD011790.pub2-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.3899\/jrheum.110569","article-title":"An international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia","volume":"38","author":"Pauer","year":"2011","journal-title":"Journal of Rheumatology"},{"issue":"5","key":"10.1002\/14651858.CD011790.pub2-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.clinthera.2012.03.003","article-title":"Safety profile and tolerability of up to 1 year of pregabalin treatment in 3 open-label extension studies in patients with fibromyalgia","volume":"34","author":"Arnold","year":"2012","journal-title":"Clinical Therapeutics"},{"issue":"7","key":"10.1002\/14651858.CD011790.pub2-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.3899\/jrheum.141196","article-title":"Efficacy and safety of pregabalin in patients with fibromyalgia and comorbid depression taking concurrent antidepressant medication: a randomized, placebo-controlled study","volume":"42","author":"Arnold","year":"2015","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0013|cit13","unstructured":"NCT01432236 A phase 3b multicenter, double-blind, randomized, placebo-controlled, 2-way crossover study of pregabalin in the treatment of fibromyalgia with concurrent antidepressant therapy for comorbid depression clinicaltrials.gov\/ct2\/show\/NCT01432236"},{"issue":"7","key":"10.1002\/14651858.CD011790.pub2-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1177\/0091270009352187","article-title":"Exposure-response analyses of the effects of pregabalin in patients with fibromyalgia using daily pain scores and patient global impression of change","volume":"50","author":"Byon","year":"2010","journal-title":"Journal of Clinical Pharmacology"},{"issue":"14","key":"10.1002\/14651858.CD011790.pub2-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1517\/14656566.2010.509717","article-title":"Treatment response to pregabalin in fibromyalgia pain: effect of patient baseline characteristics","volume":"11","author":"Emir","year":"2010","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0016|cit16","unstructured":"NCT00760474 A double-blind, placebo-controlled cross-over study in fibromyalgia subjects to examine effects of pregabalin on brain response to mechanical pain as assessed by functional magnetic resonance imaging, proton magnetic resonance spectroscopy and subjective ratings clinicaltrials.gov\/ct2\/show\/NCT00760474"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0017|cit17","unstructured":"NCT01268631 Mechanism-based choice of therapy: can treatments success in fibromyalgia patients be coupled to psychophysical pain modulation profile? clinicaltrials.gov\/ct2\/show\/NCT01268631"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0018|cit18","unstructured":"NCT01904097 Study of the brain with optic functional neuroimaging in patients with chronic pain using transcranial direct current stimulation clinicaltrials.gov\/ct2\/show\/NCT01904097"},{"issue":"6","key":"10.1002\/14651858.CD011790.pub2-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1007\/s10165-012-0803-x","article-title":"An open-label long-term phase III extension trial to evaluate the safety and efficacy of pregabalin in Japanese patients with fibromyalgia","volume":"23","author":"Ohta","year":"2013","journal-title":"Modern Rheumatology\/the Japan Rheumatism Association"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0020|cit20","doi-asserted-by":"publisher","DOI":"10.1111\/papr.12409","article-title":"Comparative efficacy of newer antidepressants in combination with pregabalin for fibromyalgia syndrome: a controlled, randomized study","volume":"Feb 19","author":"Ramzy","year":"2016","journal-title":"Pain Practice"},{"issue":"4","key":"10.1002\/14651858.CD011790.pub2-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/acr.21595","article-title":"Effect of pregabalin on sleep in patients with fibromyalgia and sleep maintenance disturbance: a randomized, placebo-controlled, 2-way crossover polysomnography study","volume":"64","author":"Roth","year":"2012","journal-title":"Arthritis Care and Research"},{"issue":"6","key":"10.1002\/14651858.CD011790.pub2-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.sleep.2009.01.009","article-title":"The effects of pregabalin on sleep disturbance symptoms among individuals with fibromyalgia syndrome","volume":"10","author":"Russell","year":"2009","journal-title":"Sleep Medicine"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0023|cit23","unstructured":"NCT01387607 A 14-week, randomized, double-blind placebo-controlled study for pregabalin in patients with fibromyalgia clinicaltrials.gov\/ct2\/show\/NCT01387607"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0024|cit24","unstructured":"NCT02146430 A randomized, double-blind, placebo- and active-controlled study of DS-5565 for treatment of pain associated with fibromyalgia clinicaltrials.gov\/ct2\/show\/NCT02146430"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0025|cit25","unstructured":"NCT02187159 A randomized, double-blind, placebo- and active-controlled study of DS-5565 for treatment of pain associated with fibromyalgia clinicaltrials.gov\/ct2\/show\/NCT02187159"},{"issue":"4","key":"10.1002\/14651858.CD011790.pub2-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/art.37842","article-title":"The fibromyalgia family study: a genome-wide linkage scan study","volume":"65","author":"Arnold","year":"2013","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1471-2474-8-27","article-title":"An internet survey of 2,596 people with fibromyalgia","volume":"8","author":"Bennett","year":"2007","journal-title":"BMC Musculoskeletal Disorders"},{"issue":"10","key":"10.1002\/14651858.CD011790.pub2-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"661","DOI":"10.2165\/11536200-000000000-00000","article-title":"A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin","volume":"49","author":"Bockbrader","year":"2010","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1016\/j.amjmed.2009.09.008","article-title":"Pathophysiology of fibromyalgia","volume":"122","author":"Bradley","year":"2009","journal-title":"The American Journal of Medicine"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.jpain.2010.01.267","article-title":"The association between incident self-reported fibromyalgia and nonpsychiatric factors: 25-years follow-up of the Adventist Health Study","volume":"11","author":"Choi","year":"2010","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1001\/jama.2014.3266","article-title":"Fibromyalgia: a clinical review","volume":"311","author":"Clauw","year":"2014","journal-title":"JAMA"},{"issue":"1-2","key":"10.1002\/14651858.CD011790.pub2-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0304-3959(97)00005-5","article-title":"The visual analogue pain intensity scale: what is moderate pain in millimetres?","volume":"72","author":"Collins","year":"1997","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD011790.pub2-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/rheumatology\/keu332","article-title":"Inadequate pain relief and large functional loss among patients with knee osteoarthritis: evidence from a prospective multinational longitudinal study of osteoarthritis real-world therapies","volume":"54","author":"Conaghan","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1002\/14651858.CD011790.pub2-BIB0034|cit34","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008244.pub3","article-title":"Milnacipran for pain in fibromyalgia in adults","author":"Cording","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"f2304","DOI":"10.1136\/bmj.f2304","article-title":"Influence of trial sample size on treatment effect estimates: meta-epidemiological study","volume":"346","author":"Dechartres","year":"2013","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD011790.pub2-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1001\/jama.2014.8166","article-title":"Association between analytic strategy and estimates of treatment outcomes in meta-analyses","volume":"312","author":"Dechartres","year":"2014","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD011790.pub2-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s00482-012-1167-z","article-title":"Fibromyalgia syndrome. General principles and coordination of clinical care and patient education","volume":"26","author":"Eich","year":"2012","journal-title":"Schmerz"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0039|cit39","unstructured":"Pregabalin Electronic Medicines Compendium www.medicines.org.uk\/emc\/medicine\/14651 (accessed 16 March 2016)"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1155\/2013\/918216","article-title":"2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary","volume":"18","author":"Fitzcharles","year":"2013","journal-title":"Pain Research Management"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0041|cit41","first-page":"2458","article-title":"Prognostic factors for the development of fibromyalgia in women with self-reported musculoskeletal pain. A prospective study","volume":"26","author":"Forseth","year":"1999","journal-title":"Journal of Rheumatology"},{"issue":"12","key":"10.1002\/14651858.CD011790.pub2-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","article-title":"GRADE guidelines: 7. Rating the quality of evidence - inconsistency","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD011790.pub2-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jclinepi.2012.01.006","article-title":"GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD011790.pub2-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jclinepi.2012.01.012","article-title":"GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0045|cit45","unstructured":"Higgins JPT Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011"},{"issue":"2","key":"10.1002\/14651858.CD011790.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.pain.2009.09.017","article-title":"How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy?","volume":"149","author":"Hoffman","year":"2010","journal-title":"Pain"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0047|cit47","first-page":"Doc 14","article-title":"13. Management of fibromyalgia syndrome - an interdisciplinary evidence-based guideline","volume":"6","author":"H\u00e4user","year":"2008","journal-title":"German Medical Science"},{"issue":"6","key":"10.1002\/14651858.CD011790.pub2-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jpain.2010.01.002","article-title":"Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome","volume":"11","author":"H\u00e4user","year":"2010","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/acr.20328","article-title":"Emotional, physical, and sexual abuse in fibromyalgia syndrome: a systematic review with meta-analysis","volume":"63","author":"H\u00e4user","year":"2011","journal-title":"Arthritis Care & Research"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.pain.2013.03.034","article-title":"Posttraumatic stress disorder in fibromyalgia syndrome: prevalence, temporal relationship between posttraumatic stress and fibromyalgia symptoms, and impact on clinical outcome","volume":"154","author":"H\u00e4user","year":"2013","journal-title":"Pain"},{"issue":"1","key":"10.1002\/14651858.CD011790.pub2-BIB0051|cit51","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010292","article-title":"Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome","author":"H\u00e4user","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/j.1532-2149.2014.00453.x","article-title":"Fibromyalgia syndrome - a somaform disorder?","volume":"18","author":"H\u00e4user","year":"2014","journal-title":"European Journal of Pain"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"Article number:","DOI":"10.1038\/nrdp.2015.22","article-title":"Fibromyalgia","volume":"1","author":"H\u00e4user","year":"2015","journal-title":"Nature Reviews Disease Primers"},{"issue":"1","key":"10.1002\/14651858.CD011790.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"f7339","DOI":"10.1136\/bmj.f7339","article-title":"Drugs for neuropathic pain","volume":"347","author":"Kalso","year":"2013","journal-title":"BMJ"},{"issue":"11","key":"10.1002\/14651858.CD011790.pub2-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1002\/j.1532-2149.2012.00234.x","article-title":"Clinical characteristics and medication uses among fibromyalgia patients newly prescribed amitriptyline, duloxetine, gabapentin, or pregabalin","volume":"65","author":"Kim","year":"2013","journal-title":"Arthritis Care and Research"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1471-2377-11-55","article-title":"Fibromyalgia and neuropathic pain - differences and similarities. A comparison of 3057 patients with diabetic painful neuropathy and fibromyalgia","volume":"11","author":"Koroschetz","year":"2011","journal-title":"BMC Neurology"},{"issue":"2","key":"10.1002\/14651858.CD011790.pub2-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"224","DOI":"10.7326\/0003-4819-107-2-224","article-title":"Meta-analysis in clinical research","volume":"107","author":"L'Abb\u00e9","year":"1987","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s00482-010-0937-8","article-title":"Influence of depression on fibromyalgia: A systematic review","volume":"24","author":"Lange","year":"2010","journal-title":"Schmerz"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00296-010-1678-9","article-title":"Candidate gene studies of fibromyalgia: a systematic review and meta-analysis","volume":"32","author":"Lee","year":"2012","journal-title":"Rheumatology International"},{"issue":"1","key":"10.1002\/14651858.CD011790.pub2-BIB0061|cit61","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007115.pub3","article-title":"Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia","author":"Lunn","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0062|cit62","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209724","article-title":"EULAR revised recommendations for the management of fibromyalgia","volume":"Epub ahead of p","author":"Macfarlane","year":"2016","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"1","key":"10.1002\/14651858.CD011790.pub2-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/j.pain.0000000000000314","article-title":"A systematic review and meta-analysis of the prevalence of chronic widespread pain in the general population","volume":"157","author":"Mansfield","year":"2016","journal-title":"Pain"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0064|cit64","volume-title":"An Evidence-based Resource for Pain Relief","author":"McQuay","year":"1998"},{"issue":"3","key":"10.1002\/14651858.CD011790.pub2-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.pain.2008.01.014","article-title":"Enriched enrolment with randomised withdrawal (EERW): Time for a new look at clinical trial design in chronic pain","volume":"135","author":"McQuay","year":"2008","journal-title":"Pain"},{"issue":"Pt A","key":"10.1002\/14651858.CD011790.pub2-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.cct.2015.07.019","article-title":"Are current standards of reporting quality for clinical trials sufficient in addressing important sources of bias?","volume":"45","author":"Mills","year":"2015","journal-title":"Contemporary Clinical Trials"},{"issue":"3","key":"10.1002\/14651858.CD011790.pub2-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0304-3959(98)00140-7","article-title":"Size is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects","volume":"78","author":"Moore","year":"1998","journal-title":"Pain"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0068|cit68","first-page":"15","article-title":"Managing potential publication bias","volume-title":"Systematic Reviews in Pain Research: Methodology Refined","author":"Moore","year":"2008"},{"issue":"3","key":"10.1002\/14651858.CD011790.pub2-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.pain.2010.05.011","article-title":"\"Evidence\" in chronic pain - establishing best practice in the reporting of systematic reviews","volume":"150","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD011790.pub2-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.pain.2010.02.039","article-title":"Fibromyalgia: moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD011790.pub2-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1136\/ard.2009.107805","article-title":"Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice","volume":"69","author":"Moore","year":"2010","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"3","key":"10.1002\/14651858.CD011790.pub2-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.pain.2010.07.013","article-title":"Numbers-needed-to-treat analyses - do timing, dropouts, and outcome matter? Pooled analysis of two randomized, placebo-controlled chronic low back pain trials","volume":"151","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"5","key":"10.1002\/14651858.CD011790.pub2-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.pain.2010.11.030","article-title":"Minimum efficacy criteria for comparisons between treatments using individual patient meta-analysis of acute pain trials: examples of etoricoxib, paracetamol, ibuprofen, and ibuprofen\/paracetamol combinations after third molar extraction","volume":"152","author":"Moore","year":"2011","journal-title":"Pain"},{"issue":"6","key":"10.1002\/14651858.CD011790.pub2-BIB0074|cit74","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/EJA.0b013e328343c569","article-title":"Mean analgesic consumption is inappropriate for testing analgesic efficacy in post-operative pain: analysis and alternative suggestion","volume":"28","author":"Moore","year":"2011","journal-title":"European Journal of Anaesthesiology"},{"issue":"12","key":"10.1002\/14651858.CD011790.pub2-BIB0075|cit75","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008242.pub2","article-title":"Amitriptyline for neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD011790.pub2-BIB0076|cit76","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.pain.2011.10.004","article-title":"Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses","volume":"153","author":"Moore","year":"2012","journal-title":"Pain"},{"issue":"4","key":"10.1002\/14651858.CD011790.pub2-BIB0077|cit77","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/anae.12148","article-title":"Pain measures and cut-offs - 'no worse than mild pain' as a simple, universal outcome","volume":"68","author":"Moore","year":"2013","journal-title":"Anaesthesia"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0078|cit78","doi-asserted-by":"publisher","first-page":"f2690","DOI":"10.1136\/bmj.f2690","article-title":"Expect analgesic failure; pursue analgesic success","volume":"346","author":"Moore","year":"2013","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD011790.pub2-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/papr.12050","article-title":"The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain","volume":"14","author":"Moore","year":"2014","journal-title":"Pain Practice"},{"issue":"4","key":"10.1002\/14651858.CD011790.pub2-BIB0080|cit80","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007938.pub3","article-title":"Gabapentin for chronic neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD011790.pub2-BIB0081|cit81","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/j.1532-2149.2013.00341.x","article-title":"Duloxetine use in chronic painful conditions - individual patient data responder analysis","volume":"18","author":"Moore","year":"2014","journal-title":"European Journal of Pain"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0082|cit82","doi-asserted-by":"crossref","unstructured":"Moore RA Wiffen PJ Eccleston C Derry S Baron R Bell RF Systematic review of enriched-enrolment randomised-withdrawal trial designs in chronic pain: a new framework for design and reporting Pain 2015 [Epub] 10.1097\/j.pain.0000000000000088","DOI":"10.1097\/j.pain.0000000000000088"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0083|cit83","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/acr.20118","article-title":"Association between physical exercise, body mass index, and risk of fibromyalgia: longitudinal data from the Norwegian Nord-Tr\u00f8ndelag Health Study","volume":"62","author":"Mork","year":"2010","journal-title":"Arthritis Care & Research"},{"issue":"1","key":"10.1002\/14651858.CD011790.pub2-BIB0084|cit84","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1526-4637.2009.00685.x","article-title":"Patient-centered perspective on treatment outcomes in chronic pain","volume":"11","author":"O'Brien","year":"2010","journal-title":"Pain Medicine"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0085|cit85","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1016\/j.pain.2013.06.001","article-title":"Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia","volume":"154","author":"Oaklander","year":"2013","journal-title":"Pain"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0086|cit86","doi-asserted-by":"crossref","unstructured":"PaPaS author and referee guidance papas.cochrane.org\/papas-documents (accessed 16 March 2016)","DOI":"10.1016\/j.acap.2016.05.082"},{"issue":"8","key":"10.1002\/14651858.CD011790.pub2-BIB0087|cit87","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s11916-013-0356-5","article-title":"Worldwide epidemiology of fibromyalgia","volume":"17","author":"Queiroz","year":"2013","journal-title":"Current Pain and Headache Reports"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0088|cit88","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0089|cit89","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00482-012-1174-0","article-title":"Etiology and pathophysiology of fibromyalgia syndrome","volume":"26","author":"Sommer","year":"2012","journal-title":"Schmerz"},{"issue":"2","key":"10.1002\/14651858.CD011790.pub2-BIB0090|cit90","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1365-2125.2008.03200.x","article-title":"Enriched enrollment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review","volume":"66","author":"Straube","year":"2008","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0091|cit91","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/1471-2474-11-150","article-title":"Pregabalin in fibromyalgia - responder analysis from individual patient data","volume":"11","author":"Straube","year":"2010","journal-title":"BMC Musculoskeletal Disorders"},{"issue":"4","key":"10.1002\/14651858.CD011790.pub2-BIB0092|cit92","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1093\/rheumatology\/kep432","article-title":"Pregabalin in fibromyalgia: meta-analysis of efficacy and safety from company clinical trial reports","volume":"49","author":"Straube","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0093|cit93","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/1471-2474-12-125","article-title":"Interference with work in fibromyalgia: effect of treatment with pregabalin and relation to pain response","volume":"12","author":"Straube","year":"2011","journal-title":"BMC Musculoskeletal Disorders"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0094|cit94","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2377-8-29","article-title":"Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials","volume":"8","author":"Sultan","year":"2008","journal-title":"BMC Neurology"},{"issue":"2","key":"10.1002\/14651858.CD011790.pub2-BIB0095|cit95","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.eplepsyres.2006.09.008","article-title":"Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery","volume":"73","author":"Taylor","year":"2007","journal-title":"Epilepsy Research"},{"issue":"6","key":"10.1002\/14651858.CD011790.pub2-BIB0096|cit96","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1365-2710.2009.01144.x","article-title":"Gabapentin and pregabalin in the treatment of fibromyalgia: a systematic review and a meta-analysis","volume":"35","author":"Tzellos","year":"2010","journal-title":"Journal of Clinical Pharmacology and Therapeutics"},{"issue":"9859","key":"10.1002\/14651858.CD011790.pub2-BIB0097|cit97","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","article-title":"Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Vos","year":"2012","journal-title":"The Lancet"},{"issue":"9","key":"10.1002\/14651858.CD011790.pub2-BIB0098|cit98","doi-asserted-by":"publisher","first-page":"e0138024","DOI":"10.1371\/journal.pone.0138024","article-title":"The prevalence and characteristics of fibromyalgia in the 2012 National Health Interview Survey","volume":"10","author":"Walitt","year":"2015","journal-title":"PLoS One"},{"issue":"11","key":"10.1002\/14651858.CD011790.pub2-BIB0099|cit99","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010567.pub2","article-title":"Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews","author":"Wiffen","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD011790.pub2-BIB0100|cit100","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee","volume":"33","author":"Wolfe","year":"1990","journal-title":"Arthritis and Rheumatism"},{"issue":"5","key":"10.1002\/14651858.CD011790.pub2-BIB0101|cit101","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care and Research"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0102|cit102","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3899\/jrheum.100594","article-title":"Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia","volume":"38","author":"Wolfe","year":"2011","journal-title":"Journal of Rheumatology"},{"issue":"4","key":"10.1002\/14651858.CD011790.pub2-BIB0103|cit103","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/j.1532-2149.2012.00234.x","article-title":"Longitudinal patterns of analgesic and central acting drug use and associated effectiveness in fibromyalgia","volume":"17","author":"Wolfe","year":"2013","journal-title":"European Journal of Pain"},{"issue":"5","key":"10.1002\/14651858.CD011790.pub2-BIB0104|cit104","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/acr.21931","article-title":"Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population","volume":"645","author":"Wolfe","year":"2013","journal-title":"Arthritis Care and Research"},{"issue":"7","key":"10.1002\/14651858.CD011790.pub2-BIB0105|cit105","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1002\/acr.22207","article-title":"What is fibromyalgia, how is it diagnosed and what does it really mean?","volume":"66","author":"Wolfe","year":"2014","journal-title":"Arthritis Care and Research"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0106|cit106","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.semarthrit.2007.09.003","article-title":"Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness","volume":"37","author":"Yunus","year":"2008","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD011790.pub2-BIB0107|cit107","doi-asserted-by":"publisher","first-page":"e247","DOI":"10.1093\/brain\/awt053","article-title":"Small fibre pathology in patients with fibromyalgia syndrome","volume":"136","author":"\u00dc\u00e7eyler","year":"2013","journal-title":"Brain"},{"issue":"10","key":"10.1002\/14651858.CD011790.pub2-BIB0108|cit108","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010782","article-title":"Anticonvulsants for fibromyalgia","author":"\u00dc\u00e7eyler","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD011790.pub2-BIB0109|cit109","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007076.pub2","article-title":"Pregabalin for acute and chronic pain in adults","author":"Moore","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD011790.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T11:33:06Z","timestamp":1679571186000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011790.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,9,29]]},"references-count":109,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011790.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,29]]}}}